Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
63.1M
-
Shares change
-
-340K
-
Total reported value, excl. options
-
$52.5M
-
Value change
-
-$351K
-
Put/Call ratio
-
0.08
-
Number of buys
-
26
-
Number of sells
-
-32
-
Price
-
$0.83
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2024
91 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2024.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 63.1M shares
of 170M outstanding shares and own 37.02% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (21.8M shares), VANGUARD GROUP INC (5.87M shares), MORGAN STANLEY (2.01M shares), MILLENNIUM MANAGEMENT LLC (1.81M shares), BlackRock, Inc. (1.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.51M shares), Vontobel Holding Ltd. (938K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (866K shares), and STATE STREET CORP (501K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.